Filtros : "Financiamento FAPESP" "Pharmaceutics" "RIBEIRO, ANA MARIA CARMONA" Limpar

Filtros



Limitar por data


  • Fonte: Pharmaceutics. Unidade: IQ

    Assuntos: NANOPARTÍCULAS, PEPTÍDEOS

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PÉREZ-BETANCOURT, Yunys et al. Characterization and differential cytotoxicity of gramicidin nanoparticles combined with cationic polymer or lipid bilayer. Pharmaceutics, v. 14, p. 1-18 art. 2053, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14102053. Acesso em: 08 out. 2025.
    • APA

      Pérez-Betancourt, Y., Zaia, R., Evangelista, M. F., Ribeiro, R. T., Roncoleta, B. M., Mathiazzi, B. I., & Carmona-Ribeiro, A. M. (2022). Characterization and differential cytotoxicity of gramicidin nanoparticles combined with cationic polymer or lipid bilayer. Pharmaceutics, 14, 1-18 art. 2053. doi:10.3390/pharmaceutics14102053
    • NLM

      Pérez-Betancourt Y, Zaia R, Evangelista MF, Ribeiro RT, Roncoleta BM, Mathiazzi BI, Carmona-Ribeiro AM. Characterization and differential cytotoxicity of gramicidin nanoparticles combined with cationic polymer or lipid bilayer [Internet]. Pharmaceutics. 2022 ; 14 1-18 art. 2053.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics14102053
    • Vancouver

      Pérez-Betancourt Y, Zaia R, Evangelista MF, Ribeiro RT, Roncoleta BM, Mathiazzi BI, Carmona-Ribeiro AM. Characterization and differential cytotoxicity of gramicidin nanoparticles combined with cationic polymer or lipid bilayer [Internet]. Pharmaceutics. 2022 ; 14 1-18 art. 2053.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics14102053
  • Fonte: Pharmaceutics. Unidade: IQ

    Assuntos: NANOPARTÍCULAS, LIPÍDEOS, CITOCINAS

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PÉREZ-BETANCOURT, Yunys et al. Cationic and biocompatible polymer/lipid nanoparticles as immunoadjuvants. Pharmaceutics, v. 13, p. 1-17 art. 1859, 2021Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics13111859. Acesso em: 08 out. 2025.
    • APA

      Pérez-Betancourt, Y., Araújo, P. M., Távora, B. de C. L. F., Pereira, D. R., Faquim-Mauro, E. L., & Carmona-Ribeiro, A. M. (2021). Cationic and biocompatible polymer/lipid nanoparticles as immunoadjuvants. Pharmaceutics, 13, 1-17 art. 1859. doi:10.3390/pharmaceutics13111859
    • NLM

      Pérez-Betancourt Y, Araújo PM, Távora B de CLF, Pereira DR, Faquim-Mauro EL, Carmona-Ribeiro AM. Cationic and biocompatible polymer/lipid nanoparticles as immunoadjuvants [Internet]. Pharmaceutics. 2021 ; 13 1-17 art. 1859.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics13111859
    • Vancouver

      Pérez-Betancourt Y, Araújo PM, Távora B de CLF, Pereira DR, Faquim-Mauro EL, Carmona-Ribeiro AM. Cationic and biocompatible polymer/lipid nanoparticles as immunoadjuvants [Internet]. Pharmaceutics. 2021 ; 13 1-17 art. 1859.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics13111859

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2025